Respirology

The injectable monoclonal antibody prevents respiratory syncytial virus in newborns and infants during their first RSV season and at-risk children during their second RSV season.

Sleep apnea is one of the most underdiagnosed sleep disorders.

The new shot called Nirsevimab—also known by the brand name Beyfortus—gives babies antibodies that provide passive immunity to RSV.

Frequent or prolonged OCS use can pose substantial health risks, but there are other options for severe asthma.

Since symptoms such as fatigue and dyspnea are common to many heart and lung diseases, pulmonary hypertension often flies under the radar of respirologists and other health professionals.

Are you up to date with the latest recommendations on treating chronic obstructive pulmonary disease? Find out here!

Researchers at the University of British Columbia have identified the cellular and molecular mechanisms, induced by a class of antibiotics, that can lead to respiratory allergies.

Co-administration poses no health risk and does not impair immune response, according to a new randomized trial.